SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories - Quaterly Results

20 May 2025 Evaluate
The Top line for the quarter ended March 2025 of Rs. 577.70 millions up 88.90% from Rs. 305.83 millions.The Total Profit for the quarter ended March 2025 of Rs. 32.38 millions grew from Rs.-12.17 millions Operating profit Margin for the quarter ended March 2025 improved to 44.83% as compared to -20.27% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 577.70 305.83 88.90 1333.62 1820.52 -26.75 1333.62 1820.52 -26.75
Other Income 6.54 25.03 -73.87 54.28 96.82 -43.94 54.28 96.82 -43.94
PBIDT 44.83 -20.27 -321.16 7.53 12.73 -40.85 7.53 12.73 -40.85
Interest 0.55 0.21 161.90 1.75 0.78 124.36 1.75 0.78 124.36
PBDT 44.28 -20.48 -316.21 5.78 11.95 -51.63 5.78 11.95 -51.63
Depreciation 5.05 5.02 0.60 20.25 19.48 3.95 20.25 19.48 3.95
PBT 39.23 -25.50 -253.84 -14.47 -7.53 92.16 -14.47 -7.53 92.16
TAX 6.85 -13.33 -151.39 7.02 -10.93 -164.23 7.02 -10.93 -164.23
Deferred Tax 6.28 2.46 155.28 6.46 -1.11 -681.98 6.46 -1.11 -681.98
PAT 32.38 -12.17 -366.06 -21.49 3.40 -732.06 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 7.76 -6.63 -217.08 0.56 0.70 -19.26 0.56 0.70 -19.26

Valiant Laboratories Share Price

67.00 0.30 (0.45%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×